Granted Patent
B2
US 7,696,324 · App. 11/519,322 · Granted Apr 13, 2010
Humanized antibodies
Assignee:
Perlan Therapeutics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of binding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of binding an ICAM-1 epitope are further provided.
Claims (1)
1. A antibody or subsequence thereof comprising SEQ ID NO: 5 and SEQ ID NO: 7.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Feb 1, 2010
From: FANG, FANG; KOHLSTAEDT, LORI; RENO, JOHN
To: PERLAN THERAPEUTICS, INC.
Reel/Frame 023880/0695 →
Continuity (3)
Continuation In Part
0955544600